A biotech startup named Bexorg is utilizing a controversial research approach to advance treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s. Their BrainEx platform connects donated human brains to a life-support system shortly after death, allowing researchers to observe cellular and metabolic functions for up to 24 hours. While Bexorg asserts that the brains are not conscious during this time, ethical concerns about awareness remain. The company has studied over 700 brains and insists that this method provides invaluable insights that surpass data derived from animal models or simulations, attracting interest from pharmaceutical companies, including Biohaven.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.vice.com/en/article/why-this-biotech-company-is-keeping-bodiless-human-brains-alive-in-a-lab/
